News
Dallas, TX - The largest-yet analysis of its kind supports the use of cardiac resynchronization therapy (CRT), either with or without defibrillator backup, in patients with NYHA class 4 heart failure, ...
TORONTO — Using data from the Resynchronization/Defibrillation for Ambulatory Heart Failure (RAFT) trial of patients with mildly symptomatic heart failure ...
Please provide your email address to receive an email when new articles are posted on . The FDA announced Medtronic has issued a recall of its implantable cardioverter defibrillators and cardiac ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results